Reference number : 276-2013-2014-Q3-00164, amendment number : , agreement type : C, recipient legal name : Medusa Medical Technologies, Incorporated|Medusa Medical Technologies, Incorporated, recipient country : CA, recipient province : NS, recipient city : Halifax|Halifax, recipient postal code : B3S 1N2, program name english : Atlantic Innovation Fund (AIF) - II, program name french : Fonds d'innovation de l'Atlantique (FIA) - II, program purpose english : nan, program purpose french : nan, agreement title english : 201101, agreement title french : 201101, agreement number : 201101, agreement value : 2625000.0, agreement start date : 2013-10-17, agreement end date : 2016-02-29, description english : Develop Siren ePCR version 5 - technology and platform, description french : Élaborer la technologie et la plateforme de la version 5 du système ePCR de Siren, expected results english : nan, expected results french : nan, additional information english : The assistance type is Conditionally Repayable Contribution., additional information french : Le type d'aide est Contribution à remboursement conditionnel., owner organization : acoa-apeca, owner organization title : Atlantic Canada Opportunities Agency | Agence de promotion économique du Canada atlantique